CA64065J4037 - Common Stock
NEOVASC INC
NASDAQ:NVCN (4/10/2023, 7:00:02 PM)
Premarket: 29.425 -0.61 (-2.01%)30.03
+0.49 (+1.66%)
Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. The company is headquartered in Richmond British Columbia, British Columbia. The company went IPO on 2001-05-23. The firm develops, manufactures, and markets products for the cardiovascular marketplace. The firm is engaged in the development of minimally invasive therapies in cardiovascular care: refractory angina and mitral valve regurgitation. Its products include the Neovasc Reducer (Reducer), for the treatment of refractory angina, and the Tiara (Tiara), for the transcatheter treatment of mitral valve disease, which is currently under clinical investigation in the United States, Canada, Israel and Europe. The firm operates through one business segment: the development, manufacturing and marketing of medical devices. The firm's subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc. The firm carries its business in Canada, the United States and Europe.
NEOVASC INC
Richmond, 5138-13562 Maycrest Way
Richmond British Columbia BRITISH COLUMBIA V6V 2J7
P: 16042704344.0
CEO: Fred Colen
Employees: 71
Website: https://www.neovasc.com/
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
VANCOUVER and MINNEAPOLIS, MN, March 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today...
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
VANCOUVER, BC, March 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Neovasc Inc. ("Neovasc" or the "Company") (NASDAQ: NVCN)(TSX: NVCN), a leader in the...
This up-and-coming medical technology star is set up to deliver market-beating gains for its long-term investors.
Here you can normally see the latest stock twits on NVCN, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: